NKTR-181

Oxycodone Substitute Shows Lower Abuse Potential

Oxycodone Substitute Shows Lower Abuse Potential

Investigators assessed the potential for abuse associated with NKTR-181, a new mu-opioid receptor agonist analgesic.

NKTR-181 for Chronic Lower Back Pain:  SUMMIT-07 Results

NKTR-181 for Chronic Lower Back Pain: SUMMIT-07 Results

By

The phase 3 SUMMIT-07 trial assessed the safety, efficacy, and tolerability of a new mu-opioid receptor agonist analgesic in adults with moderate to severe chronic lower back pain.

Oxycodone Substitute Indicates Lower Abuse Potential

Oxycodone Substitute Indicates Lower Abuse Potential

Investigators assessed the potential for abuse associated with NKTR-181, a new mu-opioid receptor agonist analgesic.

First-in-Class Opioid Analgesic Results for Chronic Back Pain

First-in-Class Opioid Analgesic Results for Chronic Back Pain

Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 study of NKTR-181 for the treatment of moderate-to-severe chronic pain.

Sign Up for Free e-Newsletters